chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 24-AUG-2015, the patient was vaccinated with an improperly stored single dose of PNEUMOVAX 23 0.5 ml, which had a lot # L003188 and an expiration date of 02-JAN-2000 (route and anatomical location of administration were not reported). The sum of hours in excursion was 1680 hours and the lowest recorded temperature reported was 27 Fahrenheit (F) (-2.777777778 Celsius (C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
8 days after receiving my first dose, I had a small rash (4-5 cm in width) develop at the site of injection. It is lightly raised, red, and burns.  My shoulder and arm muscles are sore again like it was on day 3.
I have had vertigo when I lay down since a few days after I had my shot.  I have had some headaches during the day, which I never have, but mostly bothers me at night.
J96.00 ACUTE RESPIRATORY FAILURE 11/15/2022 WEAKNESS R09.02 HYPOXIA 11/15/2022 WEAKNESS T78.40XA ALLERGIC REACTION, INIT 10/15/2021 WEAKNESS J96.00 ACUTE RESPIRATORY FAILURE 11/15/2022 LEFT ARM PAIN R09.02 HYPOXIA 11/15/2022 LEFT ARM PAIN T78.40XA ALLERGIC REACTION, INIT 10/15/2021 LEFT ARM PAIN J96.00 ACUTE RESPIRATORY FAILURE 11/15/2022 LYMPHOMA UNSPECIFIED TYPE, AXILLARY LN R09.02 HYPOXIA 11/15/2022 LYMPHOMA UNSPECIFIED TYPE, AXILLARY LN T78.40XA ALLERGIC REACTION, INIT 10/15/2021 LYMPHOMA UNSPECIFIED TYPE, AXILLARY LN J96.00 ACUTE RESPIRATORY FAILURE 11/15/2022 CHEMOTHERAPY R09.02 HYPOXIA 11/15/2022 CHEMOTHERAPY T78.40XA ALLERGIC REACTION, INIT 10/15/2021 CHEMOTHERAPY J96.00 ACUTE RESPIRATORY FAILURE 11/15/2022 ATHEROSCLEROSIS OF AORTA R09.02 HYPOXIA 11/15/2022 ATHEROSCLEROSIS OF AORTA T78.40XA ALLERGIC REACTION, INIT 10/15/2021 ATHEROSCLEROSIS OF AORTA J96.00 ACUTE RESPIRATORY FAILURE 11/15/2022 COVID-19 PNEUMONIA R09.02 HYPOXIA 11/15/2022 COVID-19 PNEUMONIA T78.40XA ALLERGIC REACTION, INIT 10/15/2021 COVID-19 PNEUMONIA J96.00 ACUTE RESPIRATORY FAILURE 11/15/2022 HYPOXIA R09.02 HYPOXIA 11/15/2022 HYPOXIA T78.40XA ALLERGIC REACTION, INIT 10/15/2021 HYPOXIA
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. During 2014, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. On or about April 2016, the patient was treated by a physician and was diagnosed with herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Pt got 1st dose of Moderna COVID-19 vaccine on 5/19/21. When she came in the DOB 5/19/21 was listed as 10/28/2001. When she came in for her 2nd dose appt. Our technician found her actual DOB was 10/28/2004. Pt too young for Moderna vaccine.
Visual scotoma in the right eye in a form of a spot and an arc from the spot towards the blind spot. First noticed a spot 8 days after the 2nd shot. 4 days later an arch appeared from the spot. Both were growing in size and intensity for a month. Now the symptoms seem to get a bit better.  Multiple retina specialist visits the doctor was suspecting one of: Cotton wool spot vs. Atypical astrocytic hamartoma vs. Inflammatory retinal lesion, right eye. Inner retinal hyper-reflective lesion was identified corresponding to the area of the scotoma. All lab work tests returned negative.
Pt returned to urgent care for complaints of redness, swelling to left arm.  Received 4 year old vaccine 01/13/04 (DTAP, IPV, MMR).  Tactile temperature at home.  (-) pain (+) pruritis.  Benadryl 26 hours return to clinic if fever, pain or swelling, redness increases.
immediately felt her heart race; her throat got really tight; lips were swollen the next day; one leg (left leg) felt numb or asleep for 4 days; tiny muscle jumps; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route in right arm single dose for COVID-19 immunisation on an unspecified date. The patient medical history was not reported. The patient's concomitant medications were not reported. After the first vaccine dose to right arm, the patient immediately felt her heart race. She reported that they watched her for a while (around for 1 hour) her heart was pounding. The patient reported that she took a diphenhydramine hydrochloride (BENADRYL) prior to going on the advice of her doctor. She reported that it got better but then once she got home, 3 hours later her throat got really tight and stayed that way for "quite a while". She reported that when that finally resolved she went to bed but when she woke up her "lips were swollen the next day". The patient reported that one leg (left leg) felt numb or asleep for 4 days and both legs had "tiny muscle jumps". Outcome of the event heart race was resolving, outcome of the event throat got really tight was resolved, outcome of the other events was unknown.  No Follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a Certified Medical Assistant referring to unspecified patients of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. On an unspecified date since September 2016, the patients were vaccinated with improperly stored doses of ROTATEQ orally, for prophylaxis. It was reported that on 11-OCT-2016, ROTATEQ with lot # M002254 with expiration date on 15-NOV-2017, was exposed to a temperature excursion of 47°F to 77°F for 1 hour time range for 1 cycle. Subsequently on 18-JAN-2017, lot # M002254, lot # M017518 with expiration date on 15-NOV-2017 and lot # M031807 with expiration date on 02-APR-2018 were exposed to a temperature excursion of 32°F to 35° for 1 hour. On 20-JAN-2017, lot # M002254 and lot # M031807 were exposed to the previously mentioned temperature excursion, but for a 30 minutes time frame. On 20-FEB-2017, the same lot number were exposed to a temperature excursion of 32°F to 35°F for 1 hour and 30 minutes time frame. On 26-APR-2017, ROTATEQ with lot # M040271 with expiration date on 30-APR-2018 was exposed to a temperature excursion of 32°F to 35°F for 1 hour time frame. On 31-MAY-2017 and on 19-JUN-2017, ROTATEQ with lot # M0402689 with expiration date on 14-MAY-2018 was exposed to a temperature excursion of 32°F to 35°F for 1 hour time frame. It was also reported, that the lowest temperature excursion was of 34.3°F and the highest of 46.6°F. Information was provided due to a data logger. Furthermore, no adverse effects were reported and no product quality issue was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA009543: US-009507513-1706USA009543: US-009507513-1707USA000714.
This spontaneous report as received from a female patient of unknown age via a field representative refers to herself. On an unknown date the patient was vaccinated with the first dose in the series of GARDASIL (route was not reported). On an unknown date the patient experienced fatigue, headaches and nausea. At the time of the report, the outcome of fatigue, headaches and nausea was unknown. Additional information is not expected.
Possible Guillain-Barre with Miller Fisher variant- paresthesia, double vision, dizziness, unsteady gait.
pt says she started having pain in her right arm, neck, shoulder pain, and her back.  Her entire body ached and she became lightheaded and dizzy.   Pt says the right arm is still swollen and sore and she also has slight nausea, lightheaded and dizziness.
I had a much more intense increase in pain in both arms that has been ongoing now and has so far persisted 2.5 days; injection site discomfort; injection site pain; headache; chills; low grade fever; This is a spontaneous report from a contactable consumer (patient, self-reported). A 39-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: ER8736 and expiry date: 30Jun2021), via an unspecified route of administration, in Left leg, on 29Apr2021 at 14:45 PM (age at vaccination: 39 years), as a single dose for COVID-19 immunization at doctor's office/urgent care. The patient was not pregnant at the time of vaccination. The patient's medical history included hypothyroid, suspected Covid-19 (Is suspected to be a post-Covid/long haul symptom that arose a few months following my clinically diagnosed Covid case in April2020 (I was infected before testing was allowed for my age and was therefore diagnosed based on symptoms and ruling out other respiratory viruses), and neurological condition with my arms (bilateral pain, weakness) (that began 7 months ago). The patient did not have any known allergies. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EW0158 and expiry date was not provided), via an unspecified route of administration, in Left leg, on 08Apr2021 at 02:45 PM (age at vaccination: 39 years), as a single dose for COVID-19 immunization at doctor's office/urgent care and had product administered at inappropriate site, Pain in extremity, vaccination site discomfort, and fatigue. Concomitant medications included Levothyroxine 88mcg and Gabapentin 300mg 3x/day. The patient did not receive any other vaccine in four weeks. It was unknown if the patient was diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that she had a neurological condition with her arms (bilateral pain, weakness) that began 7 months ago and was suspected to be a post-Covid/long haul symptom that arose a few months following her clinically diagnosed Covid case in Apr2020 (she was infected before testing was allowed for her age and was therefore diagnosed based on symptoms and ruling out other respiratory viruses). Following my first Covid vaccine 08Apr (into her left thigh to avoid her arms), she had a brief slight increase in the level of pain in both arms, but the pain level decreased in 48h when other "normal" side effects (injection site discomfort, fatigue) subsided. With her second shot (again, left thigh), on 30Apr2021 at 09:00 AM, she had a much more intense increase in pain in both arms that has been ongoing now and has so far persisted 2.5 days beyond when the "normal" side effects (injection site pain, headache, chills, low grade fever) subsided. The pain in her arms remains strong and persistent. The patient did not receive any treatment for the events. Outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Tongue is swollen; Throat is swollen; Tongue feels numb; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Tongue is swollen), PHARYNGEAL SWELLING (Throat is swollen) and HYPOAESTHESIA ORAL (Tongue feels numb) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 127721A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced SWOLLEN TONGUE (Tongue is swollen), PHARYNGEAL SWELLING (Throat is swollen) and HYPOAESTHESIA ORAL (Tongue feels numb). At the time of the report, SWOLLEN TONGUE (Tongue is swollen), PHARYNGEAL SWELLING (Throat is swollen) and HYPOAESTHESIA ORAL (Tongue feels numb) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included diabetic medication and blood pressure medication.  No treatment medication was reported.
I was diagnosed with Chronic Spontaneous Urticaria, also known as hives. They started on April 11, 2023. They've been ongoing. They appear on my chest, neck, and hands. They vary in size and shape. They last several hours each day.
08/25/2003: Phone contact with parents.  Report arm swelling in left 2x normal extending to wrist.  "Blisters" in a line 2 cm down from injection site.  Now gone.  No seizures, no inconsolable crying, no severe pain or limitation or numbness or weakness.  Felt warm to touch.  Have no thermometer.  Use Tylenol for relief.  swelling going down no more blisters.
swollen lymph nodes on left side, same side as the shot was administered. Swollen back of armpit, hurts to touch. Swollen lymph in neck, left side, same side as shot was administered.
TASTE THE VACCINE; FACE BECOME NUMB; NUMBNESS WHOLE LEFT SIDE DOWN ARM; This spontaneous report received from a patient concerned a 60 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 06-MAR-2021, the patient experienced taste the vaccine. On 06-MAR-2021, the patient experienced face become numb. On 06-MAR-2021, the patient experienced numbness whole left side down arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the face become numb, numbness whole left side down arm and taste the vaccine was not reported. This report was non-serious.
The patient experienced a headache, nausea, metallic taste and BP was 140 and it is usaully 120. Pulse and O2 was within normal limits. Patient received water and cold compress and she felt safe to drive home.
Developed bruising around the left eye orbit extending down to the left upper cheek.  Admitted to the hospital approx 10 days later with anemia, positive stool blood. Required 3 units of packed red blood cells.
shingles, included any and all of its sequelae/suffer pain as a result of Shingles; shingles, included any and all of its sequelae/ as well as other severe and personal injuries; This initial spontaneous report was received from a lawyer regarding a case in litigation, referring to a 65-year-old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On 05-APR-2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for prophylaxis (strength, dose, route of administration, anatomical location, lot number, and expiration date were not reported). On 08-NOV-2013, as a result of zoster vaccine live (ZOSTAVAX) administration, foregoing act and omissions, the patient was caused to suffered serious and dangerous side effects included: suffer pain as a result of shingles, included any and all of its sequelae, as well as other severe and personal injuries which are permanent and lasting in nature, physical pain and mental anguish, included diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications. As a result of vaccine, the patient had been caused to suffered severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. Negligence was the proximate cause of injuries, harm and economic loss which the patient suffered and/or would continue to suffer. As a result of the foregoing acts and omissions the patient required and/or would require more health care and services and did incur medical, health, incidental and related expenses. The patient was informed and believed and further alleged that the patient would in the future be required to obtained further and/or hospital care, attention and services. The patient had incurred and would continue to incur medical and related expenses. The patient also had suffered and would continue to suffer diminished capacity for the enjoyment of life, a diminished quality of life, increased risk of premature death, aggravation of preexisted conditions, activated of latent conditions, and other losses and damages. The patient's direct medical losses and cost included physician care, monitoring and treatment. The patient had incurred and would continue to incur mental and physical pain and suffering. The outcome of herpes zoster and ill-defined disorder were not recovered. The reporter considered herpes zoster and ill-defined disorder to be related to zoster vaccine live (ZOSTAVAX).  Herpes zoster meningoencephalitis, shingles and ill-defined disorder were considered to be disable events.
This spontaneous report as received from a registered nurse refers to a 14 year old patient (unspecified gender). On 18-JUN-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (dose and route were not provided) (lot # K008931 exp. 04-MAR-2017; lot # K009482 exp. 06-MAR-2017) which was exposed to below 36F for 361.81 hours. The nurse was requesting assistance in determining revaccination. In addition, excursion below 32F (31.2F) started on 13-JUL-2015. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm) and malaise (did not feel great but was not bad/had a really horrible reaction) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 011A21A) for COVID-19 immunization. No medical history reported. On Mar 4, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. In March 2021, patient experienced pain in extremity (sore arm) and malaise (did not feel great but was not bad/had a really horrible reaction). At the time of the report, pain in extremity (sore arm) and malaise (did not feel great but was not bad/had a really horrible reaction) outcome: unknown. The patient took medications for other health conditions. No treatment medication provided. This case linked to MOD-2021-363603 (patient link).
I have been experiencing discomforting neurological issues that began 5 days after my Moderna booster vaccine. The pain started in my right arm. It is a feeling of burning sensations, numbness, feelings of tightness and weakness. I also experience twitching and spasms. Around 1-2 days later, those same symptoms spread to my right leg. It has become difficult to do my normal day to day activities. In addition to these symptoms, I now have back pain and burning sensations that start from my neck and down my back. Approximately 7 days later from the start date of my symptoms, I woke up with numbness on the right side of my face which did subside later that night.
15-20 minutes after flu vaccine administered, pt. complained of "felt like she needed to lie down", then "couldn't breathe" -> went to ER, no meds administered but diagnosed "allergic reaction" and discharged.
Extremely painful menstruation, started 2 weeks early and 10 hours after shot.  Bled for 15 days straight then stopped for 2-3 days and bled for another 12-14 days.  Constant spotting.  Gum infection, heart palpation, pain in knees
This spontaneous case was reported by a patient and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (The woman who gave her the shot pulled the needle out and when she pulled it out the vaccine squirted out all over), UNDERDOSE (When she pulled it out the vaccine squirted out all over/Do not think I got the vaccination) and NO ADVERSE EVENT (Has no had any side effects/No adverse event) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L21B, 022C21A, 001A21A and 039K20A) for COVID-19 vaccination. Concurrent medical conditions included Seasonal allergy, Seafood allergy and Penicillin allergy. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-May-2022, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (The woman who gave her the shot pulled the needle out and when she pulled it out the vaccine squirted out all over) and UNDERDOSE (When she pulled it out the vaccine squirted out all over/Do not think I got the vaccination). On an unknown date, the patient experienced NO ADVERSE EVENT (Has no had any side effects/No adverse event). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (The woman who gave her the shot pulled the needle out and when she pulled it out the vaccine squirted out all over), UNDERDOSE (When she pulled it out the vaccine squirted out all over/Do not think I got the vaccination) and NO ADVERSE EVENT (Has no had any side effects/No adverse event) outcome was unknown. No concomitant medication were reported. The first booster vaccine was taken on 22-Oct-2021 and the second booster was taken on 11-May-2022. No treatment medication were reported. This case was linked to MOD-2022-616433 (Patient Link).